Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Lineage Cell Therapeutics, Inc.

NYSE: LCTX · Life Sciences · 3 alerts · CIK 876343

Share price
$0.7951Close, Nov 16
Market cap
$201M
Shares outstanding
252.95MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Lineage Cell Therapeutics, Inc. filings on SEC EDGAR ↗

8:45 AM ET Form 4
Insider Buying

Lineage Cell Therapeutics President and CEO Brian M. Culley Buys $37.1K of Stock

Brian M. Culley, President and CEO, bought 40,500 shares of Lineage Cell Therapeutics, Inc. at $0.916 a share, worth $37.1K in total on Nov 16, 2026. Shares held after the trade: 296,016 (+15.9%).

Value
$37.1K
Shares
40,500
Price
$0.9160
Role
President and CEO
Holding change
+15.9%
Trade date
Nov 16, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.